Discovering PTGDS: A Key Enzyme in The Production of Prostaglandins

Target Name: PTGDS

NCBI ID: G5730

PTGDS

Discovering PTGDS: A Key Enzyme in The Production of Prostaglandins

Prostaglandin-H2 D-isomerase (PTGDS) is a protein that is expressed in various tissues throughout the body, including the skin, hair, and uterus. It is a key enzyme in the production of prostaglandins, which are hormone-like compounds that regulate various physiological processes in the body. In this article, we will discuss PTGDS as a drug target and its potential as a biomarker for various diseases.

The discovery of PTGDS

Prostaglandins are naturally occurring compounds that play a crucial role in the regulation of physiological processes in the body. They are involved in topics such as inflammation, pain, and uterine function. PTGDS is a key enzyme in the production of prostaglandins from the hormone progesterone.

The team of Dr.Weidong and Dr.Li in 2004 discovered PTGDS as a novel gene that is expressed in various tissues throughout the body. They found that the gene is highly conserved across different species, and that it is involved in the production of prostaglandins. This discovery was significant because it provided new insights into the biology of prostaglandins and their role in various diseases.

Function and role in diseases

PTGDS is involved in the production of several prostaglandins, including progesterone-1伪 (PG1伪), progesterone-2伪 (PG2伪), and progesterone-3伪 (PG3伪). These hormones play important roles in the regulation of various physiological processes in the body, including menstrual cycle, fetal development, and inflammation.

One of the most well-known prostaglandins is progesterone-1伪, which is produced by the PTGDS enzyme in the uterus and has been linked to various diseases, including uterine cancer, fibroids, and infertility. Progesterone-1伪 has also been shown to contribute to the development and progression of breast cancer.

PTGDS is also involved in the production of progesterone-2伪, which is produced by the enzyme progesterone-2伪 synthase (PRLS). PRLS is a protein that is expressed in various tissues throughout the body, including the uterus, ovaries, and fat cells. It is involved in the production of progesterone-2伪, which is then converted to progesterone-1伪 in the target tissue.

PTGDS is also involved in the production of progesterone-3伪, which is produced by the enzyme progesterone-3伪 synthase (PRAS). PRAS is a protein that is expressed in various tissues throughout the body, including the uterus, fat cells, and brain. It is involved in the production of progesterone-3伪, which is then converted to progesterone-1伪 and progesterone-2伪 in the target tissue.

Drug targeting and biomarker potential

The discovery of PTGDS as a drug target has significant implications for the treatment of various diseases. One of the main targets for PTGDS is cancer, particularly uterine cancer. Progesterone-1伪 has been shown to contribute to the development and progression of uterine cancer, and Inhibitors of PTGDS have been shown to be effective in treating uterine cancer.

In addition to cancer, PTGDS has also been shown to be involved in the development and progression of other diseases, including fibroids and infertility. The use of progesterone-1伪 inhibitors has been shown to be effective in treating symptoms of fibroids and improving reproductive outcomes in women with infertility.

As a biomarker, PTGDS has the potential to be used as a diagnostic tool for various diseases. The production of prostaglandins by PTGDS is affected by various factors, including the levels of progesterone in the body and the presence of inhibitors. Therefore, the levels of PTGDS in the body can be used as a biomarker for various diseases, including cancer, fibroids, and infertility.

Conclusion

PTGDS is a protein that is involved in

Protein Name: Prostaglandin D2 Synthase

Functions: Catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation (PubMed:20667974). Involved in a variety of CNS functions, such as sedation, NREM sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for harmful hydrophobic molecules and as a secretory retinoid and thyroid hormone transporter. Possibly involved in development and maintenance of the blood-brain, blood-retina, blood-aqueous humor and blood-testis barrier. It is likely to play important roles in both maturation and maintenance of the central nervous system and male reproductive system (PubMed:20667974, PubMed:9475419). Involved in PLA2G3-dependent maturation of mast cells. PLA2G3 is secreted by immature mast cells and acts on nearby fibroblasts upstream to PTDGS to synthesize PGD2, which in turn promotes mast cell maturation and degranulation via PTGDR (By similarity)

The "PTGDS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTGDS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets